Posted Nov. 19, 2013 at 5:25 p.m.

Premium Lock Chelsea Therapeutics raises $21.4M in stock offering

Published: 2013-11-19 17:25:14
Updated: 2013-11-19 17:25:14

Chelsea Therapeutics logo Chelsea Therapeutics

Chelsea plans to use proceeds from the offering to fund its droxidopa drug program, including the company's work on drug candidate Northera, a compound in clinical testing to treat neurogenic orthostatic hypotension or NOH....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders